Niacin will continue to fall out of favor for dyslipidemia

February 2013

Niacin will continue to fall out of favor for dyslipidemia.

Recent studies suggest that adding niacin to a statin does NOT improve outcomes more than a statin alone.

Researchers hoped that adding niacin would lower CV risk by increasing HDL...even in patients with LDL levels of about 70 mg/dL.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote